# Upland Software, Inc.: financial statements, quarterly

UPLD · Nasdaq · CIK 1505155 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/upld.md) · [Financials](/companies/upld/financials.md) · [Filings](/companies/upld/filings.md) · [Insiders](/companies/upld/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/upld/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [74.1](/filings/0001505155-24-000108.md) | [72.2 d](/filings/0001505155-26-000007.md) | [70.7](/filings/0001505155-25-000056.md) | [69.3](/filings/0001505155-25-000091.md) | [66.7](/filings/0001505155-25-000106.md) | [68.0 d](/filings/0001505155-26-000007.md) | [63.7](/filings/0001505155-26-000036.md) | [53.4](/filings/0001505155-26-000070.md) | [50.5](/filings/0001505155-25-000106.md) | [49.3 d](/filings/0001505155-26-000007.md) | [48.7](/filings/0001505155-26-000036.md) | [49.1](/filings/0001505155-26-000070.md) |
| Cost of revenue | $m | [22.9](/filings/0001505155-24-000108.md) | [23.7 d](/filings/0001505155-26-000007.md) | [21.0](/filings/0001505155-25-000056.md) | [20.5](/filings/0001505155-25-000091.md) | [19.7](/filings/0001505155-25-000106.md) | [19.9 d](/filings/0001505155-26-000007.md) | [18.0](/filings/0001505155-26-000036.md) | [13.4](/filings/0001505155-26-000070.md) | [11.7](/filings/0001505155-25-000106.md) | [11.6 d](/filings/0001505155-26-000007.md) | [11.9](/filings/0001505155-26-000036.md) | [11.7](/filings/0001505155-26-000070.md) |
| Gross profit | $m | [51.2](/filings/0001505155-24-000108.md) | [48.5 d](/filings/0001505155-26-000007.md) | [49.7](/filings/0001505155-25-000056.md) | [48.9](/filings/0001505155-25-000091.md) | [47.0](/filings/0001505155-25-000106.md) | [48.2 d](/filings/0001505155-26-000007.md) | [45.6](/filings/0001505155-26-000036.md) | [39.9](/filings/0001505155-26-000070.md) | [38.8](/filings/0001505155-25-000106.md) | [37.7 d](/filings/0001505155-26-000007.md) | [36.8](/filings/0001505155-26-000036.md) | [37.5](/filings/0001505155-26-000070.md) |
| Research and development | $m | [12.7](/filings/0001505155-24-000108.md) | [11.7 d](/filings/0001505155-26-000007.md) | [12.5](/filings/0001505155-25-000056.md) | [12.2](/filings/0001505155-25-000091.md) | [11.4](/filings/0001505155-25-000106.md) | [11.3 d](/filings/0001505155-26-000007.md) | [11.5](/filings/0001505155-26-000036.md) | [9.8](/filings/0001505155-26-000070.md) | [7.9](/filings/0001505155-25-000106.md) | [7.3 d](/filings/0001505155-26-000007.md) | [8.0](/filings/0001505155-26-000036.md) | [7.8](/filings/0001505155-26-000070.md) |
| Operating income | $m | [(7.7)](/filings/0001505155-24-000108.md) | [(9.4) d](/filings/0001505155-26-000007.md) | [(91.6)](/filings/0001505155-25-000056.md) | [(5.4)](/filings/0001505155-25-000091.md) | [(3.3)](/filings/0001505155-25-000106.md) | [(2.0) d](/filings/0001505155-26-000007.md) | [(1.1)](/filings/0001505155-26-000036.md) | [(7.0)](/filings/0001505155-26-000070.md) | [5.3](/filings/0001505155-25-000106.md) | [7.2 d](/filings/0001505155-26-000007.md) | [5.0](/filings/0001505155-26-000036.md) | [(29.7)](/filings/0001505155-26-000070.md) |
| Interest expense | $m | [2.5](/filings/0001505155-24-000108.md) | [5.3 d](/filings/0001505155-25-000024.md) | [5.0](/filings/0001505155-25-000056.md) | [5.1](/filings/0001505155-25-000091.md) | [(2.3)](/filings/0001505155-24-000108.md) | [1.3 d](/filings/0001505155-25-000024.md) | [2.4](/filings/0001505155-25-000056.md) | [4.1](/filings/0001505155-25-000091.md) | not reported | not reported | not reported | not reported |
| Income tax | $m | [(1.5)](/filings/0001505155-24-000108.md) | [0.6 d](/filings/0001505155-26-000007.md) | [(0.5)](/filings/0001505155-25-000056.md) | [1.2](/filings/0001505155-25-000091.md) | [0.5](/filings/0001505155-25-000106.md) | [1.4 d](/filings/0001505155-26-000007.md) | [(1.3)](/filings/0001505155-26-000036.md) | [(0.2)](/filings/0001505155-26-000070.md) | [(0.3)](/filings/0001505155-25-000106.md) | [2.0 d](/filings/0001505155-26-000007.md) | [1.0](/filings/0001505155-26-000036.md) | [0.8](/filings/0001505155-26-000070.md) |
| Net income | $m | [(8.7)](/filings/0001505155-24-000108.md) | [(16.0) d](/filings/0001505155-26-000007.md) | [(96.1)](/filings/0001505155-25-000056.md) | [(11.4)](/filings/0001505155-25-000091.md) | [(1.7)](/filings/0001505155-25-000106.md) | [(3.4) d](/filings/0001505155-26-000007.md) | [(25.8)](/filings/0001505155-26-000036.md) | [(13.0)](/filings/0001505155-26-000070.md) | [(1.1)](/filings/0001505155-25-000106.md) | [1.1 d](/filings/0001505155-26-000007.md) | [(1.2)](/filings/0001505155-26-000036.md) | [(35.3)](/filings/0001505155-26-000070.md) |
| Diluted EPS | $ per share | [(0.31)](/filings/0001505155-24-000108.md) | not reported | [(3.37)](/filings/0001505155-25-000056.md) | [(0.47)](/filings/0001505155-25-000091.md) | [(0.12)](/filings/0001505155-25-000106.md) | not reported | [(0.97)](/filings/0001505155-26-000036.md) | [(5.08)](/filings/0001505155-26-000070.md) | [(0.09)](/filings/0001505155-25-000106.md) | not reported | [(0.09)](/filings/0001505155-26-000036.md) | [(12.53)](/filings/0001505155-26-000070.md) |
| Basic EPS | $ per share | [(0.31)](/filings/0001505155-24-000108.md) | not reported | [(3.37)](/filings/0001505155-25-000056.md) | [(0.47)](/filings/0001505155-25-000091.md) | [(0.12)](/filings/0001505155-25-000106.md) | not reported | [(0.97)](/filings/0001505155-26-000036.md) | [(5.08)](/filings/0001505155-26-000070.md) | [(0.09)](/filings/0001505155-25-000106.md) | not reported | [(0.09)](/filings/0001505155-26-000036.md) | [(12.53)](/filings/0001505155-26-000070.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [240](/filings/0001628280-23-036456.md) | [237](/filings/0001505155-25-000024.md) | [232](/filings/0001505155-24-000040.md) | [232](/filings/0001505155-24-000069.md) | [59.7](/filings/0001505155-24-000108.md) | [56.4](/filings/0001505155-26-000007.md) | [33.7](/filings/0001505155-25-000056.md) | [41.0](/filings/0001505155-25-000091.md) | [22.8](/filings/0001505155-25-000106.md) | [29.4](/filings/0001505155-26-000070.md) | [29.8](/filings/0001505155-26-000036.md) | [31.0](/filings/0001505155-26-000070.md) |
| Current assets | $m | [307](/filings/0001628280-23-036456.md) | [300](/filings/0001505155-25-000024.md) | [289](/filings/0001505155-24-000040.md) | [290](/filings/0001505155-24-000069.md) | [118](/filings/0001505155-24-000108.md) | [118](/filings/0001505155-26-000007.md) | [84.2](/filings/0001505155-25-000056.md) | [83.4](/filings/0001505155-25-000091.md) | [65.1](/filings/0001505155-25-000106.md) | [75.3](/filings/0001505155-26-000070.md) | [73.5](/filings/0001505155-26-000036.md) | [70.1](/filings/0001505155-26-000070.md) |
| Total assets | $m | [894](/filings/0001628280-23-036456.md) | [870](/filings/0001505155-25-000024.md) | [755](/filings/0001505155-24-000040.md) | [740](/filings/0001505155-24-000069.md) | [555](/filings/0001505155-24-000108.md) | [530](/filings/0001505155-26-000007.md) | [457](/filings/0001505155-25-000056.md) | [442](/filings/0001505155-25-000091.md) | [409](/filings/0001505155-25-000106.md) | [413](/filings/0001505155-26-000070.md) | [403](/filings/0001505155-26-000036.md) | [357](/filings/0001505155-26-000070.md) |
| Current liabilities | $m | [129](/filings/0001628280-23-036456.md) | [131](/filings/0001505155-25-000024.md) | [123](/filings/0001505155-24-000040.md) | [122](/filings/0001505155-24-000069.md) | [119](/filings/0001505155-24-000108.md) | [120](/filings/0001505155-26-000007.md) | [101](/filings/0001505155-25-000056.md) | [89.6](/filings/0001505155-25-000091.md) | [84.0](/filings/0001505155-25-000106.md) | [93.8](/filings/0001505155-26-000070.md) | [87.2](/filings/0001505155-26-000036.md) | [80.2](/filings/0001505155-26-000070.md) |
| Total liabilities | $m | [628](/filings/0001628280-23-036456.md) | [626](/filings/0001505155-25-000024.md) | [616](/filings/0001505155-24-000040.md) | [613](/filings/0001505155-24-000069.md) | [432](/filings/0001505155-24-000108.md) | [425](/filings/0001505155-26-000007.md) | [370](/filings/0001505155-25-000056.md) | [358](/filings/0001505155-25-000091.md) | [329](/filings/0001505155-25-000106.md) | [332](/filings/0001505155-26-000070.md) | [324](/filings/0001505155-26-000036.md) | [314](/filings/0001505155-26-000070.md) |
| Long-term debt | $m | not reported | [474](/filings/0001505155-25-000024.md) | not reported | not reported | not reported | [287](/filings/0001505155-26-000007.md) | not reported | not reported | not reported | [225](/filings/0001505155-26-000007.md) | not reported | not reported |
| Current portion of debt | $m | not reported | [3.2](/filings/0001505155-25-000024.md) | not reported | not reported | not reported | [3.2](/filings/0001505155-26-000007.md) | not reported | not reported | not reported | [7.7](/filings/0001505155-26-000007.md) | not reported | not reported |
| Shareholders' equity | $m | [149](/filings/0001505155-24-000108.md) | [126](/filings/0001505155-26-000007.md) | [20.1](/filings/0001505155-25-000091.md) | [6.5](/filings/0001505155-25-000106.md) | [0.9](/filings/0001505155-25-000106.md) | [(18.3)](/filings/0001505155-26-000070.md) | [(37.8)](/filings/0001505155-26-000070.md) | [(42.4)](/filings/0001505155-26-000070.md) | [(47.3)](/filings/0001505155-25-000106.md) | [(48.4)](/filings/0001505155-26-000070.md) | [(52.4)](/filings/0001505155-26-000070.md) | [(89.8)](/filings/0001505155-26-000070.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [18.3 d](/filings/0001505155-24-000108.md) | [8.8 d](/filings/0001505155-26-000007.md) | [5.1](/filings/0001505155-25-000056.md) | [5.5 d](/filings/0001505155-25-000091.md) | [4.3 d](/filings/0001505155-25-000106.md) | [9.3 d](/filings/0001505155-26-000007.md) | [8.3](/filings/0001505155-26-000036.md) | [3.3 d](/filings/0001505155-26-000070.md) | [6.9 d](/filings/0001505155-25-000106.md) | [7.3 d](/filings/0001505155-26-000007.md) | [5.6](/filings/0001505155-26-000036.md) | [5.4 d](/filings/0001505155-26-000070.md) |
| Capital expenditure | $m | [0.5 d](/filings/0001505155-24-000108.md) | [0.2 d](/filings/0001505155-26-000007.md) | [0.2](/filings/0001505155-25-000056.md) | [0.3 d](/filings/0001505155-25-000091.md) | [0.1 d](/filings/0001505155-25-000106.md) | [0.3 d](/filings/0001505155-26-000007.md) | [0.4](/filings/0001505155-26-000036.md) | [0.6 d](/filings/0001505155-26-000070.md) | [0.2 d](/filings/0001505155-25-000106.md) | [0.1 d](/filings/0001505155-26-000007.md) | [0.1](/filings/0001505155-26-000036.md) | [0.1 d](/filings/0001505155-26-000070.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [31.7](/filings/0001628280-23-036456.md) | [32.3](/filings/0001505155-24-000040.md) | [32.5](/filings/0001505155-24-000069.md) | [32.6](/filings/0001505155-24-000108.md) | [28.9](/filings/0001505155-25-000056.md) | [27.3](/filings/0001505155-25-000091.md) | [27.3](/filings/0001505155-25-000106.md) | [28.2](/filings/0001505155-26-000036.md) | [2.9](/filings/0001505155-26-000070.md) | [28.8](/filings/0001505155-25-000106.md) | [29.2](/filings/0001505155-26-000036.md) | [2.9](/filings/0001505155-26-000070.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 2,957,191 at 2026-08-10, from the cover of the [10-Q filed 2026-08-14](/filings/0001505155-26-000070.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.